Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment

Gomez Cadena, Alejandra; Spehner, Laurie; Kroemer, Marie; Khelil, Myriam Ben; Bouiller, Kevin; Verdeil, Grégory; Trabanelli, Sara; Borg, Christophe; Loyon, Romain; Jandus, Camilla

doi:10.1038/s41423-020-00596-2

Scientific article

Open access

English

Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment

ContributorsGomez Cadena, Alejandra; Spehner, Laurie; Kroemer, Marie; Khelil, Myriam Ben; Bouiller, Kevin; Verdeil, Grégory; Trabanelli, Sara; Borg, Christophe; Loyon, Romain; Jandus, Camilla

Published inCellular & Molecular Immunology, vol. 18, no. 2, p. 484-486

Publication date2021

Keywords

COVID-19/blood/immunology/pathology
Humans
Immunity
Innate
Interleukin-33/metabolism
Lymphocytes/immunology
NK Cell Lectin-Like Receptor Subfamily K/metabolism

Affiliation

Faculté de médecine / Section de médecine fondamentale / Département de pathologie et immunologie

Research group

Ciblage des lymphocytes sécrétant des cytokines (1015)

Funding

Swiss National Science Foundation - PRIMA PR00P3_179727

Citation (ISO format)

GOMEZ CADENA, Alejandra et al. Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment. In: Cellular & Molecular Immunology, 2021, vol. 18, n° 2, p. 484–486. doi: 10.1038/s41423-020-00596-2

Article (Published version)

CC BY

Identifiers

PID : unige:151644
DOI : 10.1038/s41423-020-00596-2
PMID : 33318627

ISSN of the journal1672-7681

167views

80downloads

Creation05/07/2021 3:40:00 PM

First validation05/07/2021 3:40:00 PM

Update time03/16/2023 12:34:20 AM

Status update03/16/2023 12:34:19 AM

Last indexation05/06/2024 7:35:34 AM

Archive ouverte UNIGE

Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment

Technical informations